Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 1 December 2020, 04:40 HKT/SGT
Share:
    

Source: China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical records 29.4% revenue growth in October

HONG KONG, Dec 1, 2020 - (ACN Newswire) - China Shineway Pharmaceutical (stock code: 2877.HK) recorded 29.4% revenue growth for October 2020 in comparison with the same period last year, as sales of injection products, soft capsule products, granule products, TCM formula granules, and other dosage forms went up 38.9%, 17.4%, 38.1%, 7.9% and 54.0% respectively.



Topic: Press release summary
Sectors: Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



China Shineway Pharmaceutical Group Limited
Nov 30, 2020 14:00 HKT/SGT
Shineway Pharmaceutical (2877.HK) recorded 29.4% revenue growth for October 2020
More news >>
 News Alerts
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: